All News

    ctDNA Status May Predict Disease-Free Survival With Celebrex in Colon Cancer

    January 25th 2025, 7:58pm

    Article

    Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA who received Celebrex had significantly better rates versus placebo.

    Afinitor Plus Somatuline May Improve Survival in Aggressive GEP-NETs

    January 25th 2025, 7:36pm

    Video

    Dr. Susumu Hijioka spoke about the benefit of this combination therapy in patients with unresectable or recurrent GEP-NETs, particularly those with high Ki-67 scores.

    CRT and Chemo May Not Improve Survival in Resected Gallbladder Cancer

    January 25th 2025, 5:43pm

    Article

    Among patients with resected gallbladder cancer, the addition of chemoradiation to chemotherapy treatment did not improve relapse-free survival.

    Opdivo Plus Yervoy May Improve Survival and Responses in Frontline uHCC

    January 25th 2025, 4:00pm

    Article

    Opdivo plus Yervoy shows efficacy and manageable safety as first-line treatment for unresectable hepatocellular carcinoma in the CheckMate 9DW study.

    Aspirin May Reduce Recurrence in PI3K-mutated Colorectal Cancer

    January 25th 2025, 3:02pm

    Article

    Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance of upfront genomic testing.

    Cabometyx Shows Promise for Treating Advanced NETs Originating in the GI Tract

    January 24th 2025, 8:39pm

    Article

    A study showed Cabometyx improved time before disease progression in advanced digestive NETs compared with placebo.

    Bezuclastinib Plus Sutent May Be Safe and Effective in GIST

    January 24th 2025, 6:30pm

    Article

    Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

    When Cancer Is Not the Only Thing Going On

    January 24th 2025, 6:00pm

    Article

    My journey as a foster parent paralleled my cancer experience, both demanding resilience, support, and a redefinition of normal.

    Second Cancer Risk Heightened After Appendiceal Adenocarcinoma Diagnosis

    January 24th 2025, 5:18pm

    Article

    Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including colorectal and prostate cancers.

    FDA Approves GRAFAPEX/Fludarabine Before alloHSCT in AML and MDS

    January 24th 2025, 4:15pm

    Article

    The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome prior to alloHSCT.